AMILORIDE IN THE TREATMENT OF PRIMARY HYPERALDOSTERONISM AND ESSENTIAL HYPERTENSION

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Clinical and experimental pharmacology & physiology. Supplement

• Publication date

  1977-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2265.1977.tb01307.xPMID 354830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of spironolactone on endogenous steroid metabolism in man.

  1976cited by this paper
• An international collaborative study of renin assay: establishment of the international reference preparation of human renin.

  1975cited by this paper
• Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.

  1974cited by this paper
• Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.

  1973cited by this paper
• Amiloride in primary hyperaldosteronism with chronic peptic ulceration.

  1973cited by this paper
• Protective effect of frusemide in acute tubular necrosis and acute renal failure.

  1973cited by this paper
• The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.

  1973cited by this paper
• Simultaneous measurement of total exchangeable potassium and sodium using 43 K and 24 Na.

  1973cited by this paper
• A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man.

  1973cited by this paper
• Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Aldosterone Excess, and Low Plasma Renin

  1972cited by this paper
• Quadric analysis in the preoperative distinction between patients with and without adrenocortical tumors in hypertension with aldosterone excess and low plasma renin.

  1971cited by this paper
• Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors.

  1971cited by this paper
• Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical States

  1971cited by this paper
• Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.

  1970cited by this paper
• Clinical evaluation of amiloride, a potassium‐sparing diuretic

  1969cited by this paper
• Amiloride: A Potassium‐Sparing Natriuretic Agent

  1968cited by this paper
• Aldosteronism in hypertension. The spironolactone response test.

  1968cited by this paper
• A high sensitivity shadow-shield whole body monitor with scanning-bed and tilting chair geometries, incorporated in a mobile laboratory.

  1967cited by this paper
• Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone.

  1965cited by this paper
• A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.

  1964cited by this paper
• Plasma Renin in a Case of Conn's Syndrome with Fibrinoid Lesions: Use of Spironolactone in Treatment

  1964cited by this paper
• The estimation of renin in human plasma.

  1964cited by this paper

• An ERα-Dependent Hypoxia Response Defines EMT-Adjacent Tumour Regions and Suppresses the Pro-survival Effects of Amiloride in Estrogen Receptor-Positive Breast Cancer

  2025cites this paper
• Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society

  2023cites this paper
• Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.

  2023cites this paper
• МЕДИКАМЕНТОЗНЕ ЛІКУВАННЯ ПЕРВИННОГО ГІПЕРАЛЬДОСТЕРОНІЗМУ

  2020cites this paper
• Amiloride: A review

  2020cites this paper
• Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.

  2019cites this paper
• Regulation of aldosterone secretion by Cav1.3

  2016cites this paper
• Pharmacological treatment of aldosterone excess.

  2015cites this paper
• Na(+)/H(+) exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2(+) mobilization.

  2013cites this paper
• ENaC inhibition stimulates Cl- secretion in the mouse cortical collecting duct through an NKCC1-dependent mechanism.

  2012cites this paper
• The effect of diuretics on lymphocyte magnesium and potassium.

  2009cites this paper
• Moderne pharmakologische Aspekte der Therapie des Aldosteronismus

  2006cites this paper
• Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.

  2004cites this paper
• Volume Independent Stimulation of Renin Secretion by a Single Dose of Amiloride in Man

  2002cites this paper
• A review of the medical treatment of primary aldosteronism

  2001cites this paper
• Hormonal and humeral considerations in hypertensive disease.

  1997cites this paper
• Variation of phenotype in patients with glucocorticoid remediable aldosteronism.

  1996cites this paper
• Role of macula densa in diuretics-induced renin release.

  1990cites this paper
• Disturbances in salt and water metabolism in hypertension.

  1989cites this paper
• HORMONES AND HYPERTENSION

  1989cites this paper
• 7 Disorders of mineralocorticoid activity

  1985cites this paper
• Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy.

  1984cites this paper
• Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.

  1984cites this paper
• Effects of amiloride on plasma and total body potassium, blood pressure, and the renin‐angiotensin‐aldosterone system in thiazide‐treated hypertensive patients

  1983cites this paper
• Primary aldosteronism: how hard should we look?

  1983cites this paper
• Primary Aldosteronism: Pathophysiology, Diagnosis and Treatment

  1983cites this paper
• The Effect of Amiloride on the Renin—Aldosterone System in Primary Hyperaldosteronism and Bartter's Syndrome

  1982cites this paper
• Amiloride in primary hyperaldosteronism

  1982cites this paper
• Identifying aldosterone-producing adenoma.

  1982cites this paper
• 2 Primary hyperaldosteronism

  1981cites this paper
• Triamterene‐thiazide combination: Alternative therapy for primary aldosteronism

  1981cites this paper
• Attenuation of Diuretic‐Induced Hypokalemia by Amiloride, a Potassium‐Sparing Agent

  1981cites this paper
• Clinical and pathological aspects of primary aldosteronism

  1981cites this paper
• Renin-angiotensin-aldosterone and hypertension.

  1980cites this paper
• Sodium and hypertension. A review of the role of sodium in pathogenesis and the action of diuretic drugs.

  1980cites this paper
• Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus.

  1979cites this paper
• Principles of drug treatment for hypertension: indications for treatment and for selection of drugs.

  1979cites this paper
• Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease.

  1979influential citation
• Severe hypertension in primary aldosteronism and good response to surgery.

  1979cites this paper